The current retatrutide supplier landscape is significantly shifting , presenting complexities for biotechnology firms. Currently, the quantity of known suppliers is quite constrained, primarily centered on custom synthesis providers . Regional presence is heavily weighted in the East , with growing presence from US suppliers. Obtaining a reliable